Feature Stories

Key points

  • CDC is a leader in the fight against antimicrobial resistance (AR).
  • Through its AR Solutions Initiative, CDC works with partners to drive aggressive action and empower the nation to respond to this global threat.
  • Check out the stories below that feature solutions in action to combat AR.
ARCH project Botswana lab team processes sample

CDC Solutions to Combat Antimicrobial Resistance

Speaker headshots on purple background. Text says Vaccines: A Critical Tool in the Fight Against Antimicrobial Resistance

Experts Discuss Use of Vaccines to Curb Antimicrobial Resistance

Experts discuss a commitment to pursue innovative approaches to utilizing vaccines to help curb AR.
AMR Exchange Combating AMR Together

Combating Antimicrobial Resistance through Global Networks

Experts discuss how the Global AR Lab & Response Network strengthens the global fight against AR.
Laboratorians prepare strains to test for antimicrobial resistance.

Detecting Antimicrobial Resistance in Brazil

CDC and partners work to help laboratories in Brazil better detect and report critical AR threats.
AMR Exchange: Addressing Health Inequities by Strengthening Antibiotic Stewardship.

Experts Discuss Reducing Health Disparities by Improving Antibiotic Use

CDC and partners discuss strategies to achieve the highest quality of care for all patients.
Wastewater detection helps protect people from antimicrobial resistance.

Testing Wastewater Helps Protect Against Antimicrobial Resistance and COVID-19

AR investments in wastewater detection helped protect people from COVID-19.
Lab team processes sample for testing.

Global Projects to Detect and Respond to Antimicrobial Resistance

CDC invests in multi-country projects to help stop spread of resistance.
Illustration of gonorrhea.

Pilot to Test for Drug-Resistant Gonorrhea in Emergency Departments

CDC and health departments work to expand drug-resistant gonorrhea surveillance to emergency rooms.
Health equity and antimicrobial resistance.

CDC Prioritizes Health Equity Related to Antimicrobial Resistance

CDC programs are prioritizing health equity disparities/inequality related to AR.
Healthcare worker cleaning patient room.

Antimicrobial Resistance Investments at Work: Protecting People from COVID-19

CDC investments proved to integral in reducing spread of AR and COVID-19 in healthcare facilities. 
AMR in a Changed World: Building Resilient Systems for Today and Tomorrow

Experts Discuss Addressing Antimicrobial Resistance after COVID-19

Experts discuss antimicrobial resistance response in a post-pandemic world through a One Health lens...
6 of the 18 most alarming antibiotic resistant threats cost the U.S. more than $4.6 billion annually.

CDC Partners Estimate Healthcare Cost of Antimicrobial-resistant Infections

CDC and experts worked to estimate the healthcare cost of AR threats in the U.S. annually.

Archived Stories

U.S. Antibiotic Awareness Week 2022 Focuses on Prevention

Exploring New Approaches to Diagnose Clostridiodes difficile Infections

Tailoring Antibiotic Treatment For Patients with Cystic Fibrosis

CDC is Taking Global Action to Fight AR

Tracking Antibiotic Resistance in Kenya and Senegal

CDC Core Elements to Help Resource-limited Settings Improve Antibiotic Use

Antibiotic Resistance: A Global Threat

Combating Antimicrobial Resistance in Vietnam

Pilot Program with HP Accelerates Antibiotic Testing

Stop Spread of Unusual Antibiotic Resistance

Stopping C. auris in an Oklahoma Hospital

New CDC Network Established as Fungal Threat Emerges

C. auris: CDC’s Response to a Global Emerging Threat

Improving Antibiotic Prescribing with Rapid Diagnostics and Education

CDC and Partners Tackle Drug-resistant TB in India

Newly Reported Gene, mcr-1, Threatens Last-Resort Antibiotics

Print
Content Source:
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)